Acetazolamida

Quick links to important sections

Acetazolamida

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acetazolamida

What is Acetazolamida?

Acetazolamide is a pharmacological agent classified as a carbonic anhydrase inhibitor. It functions by interfering with the activity of the enzyme carbonic anhydrase, which plays a critical role in the regulation of acid-base balance and fluid dynamics within the body.

Mechanism of Action

The primary function of acetazolamide is to inhibit the enzyme that facilitates the reversible reaction between carbon dioxide and water into bicarbonate and hydrogen ions. By blocking this process, the medication promotes the excretion of bicarbonate, sodium, and potassium through the renal system. This process results in an increase in urine output and a subsequent reduction in the concentration of certain fluids.

Clinical Uses

Acetazolamide is utilized across various medical contexts to manage conditions related to fluid pressure and metabolic balance. Common applications include:

  • Ocular Pressure Management: It is used to reduce intraocular pressure in individuals with certain types of glaucoma by decreasing the production of aqueous humor in the eye.
  • Edema Control: It may be employed as a diuretic to assist in the removal of excess fluid accumulation caused by congestive heart failure or medication-induced fluid retention.
  • Altitude Adjustment: The medication is used to help the body acclimate to high altitudes, addressing the physiological changes that occur during rapid ascent.
  • Seizure Disorders: In specific cases, it is used as an adjunctive therapy in the management of certain types of epilepsy.

Physiological Impact

Beyond its diuretic effects, acetazolamide induces a state of metabolic acidosis. This change in blood chemistry can stimulate respiratory drive, which is one of the reasons it is considered in the context of altitude-related respiratory adjustments. By altering how the kidneys handle electrolytes and bicarbonate, the medication influences the systemic pH level and the distribution of fluids across various biological barriers, such as the blood-brain barrier and the ocular environment.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. MedlinePlus Drug Information on Acetazolamide

What side effects are possible with Acetazolamida?

Acetazolamida is a sulfonamide derivative, and its safety profile is dominated by effects related to this chemical class and its inhibition of carbonic anhydrase.

Serious Adverse Reactions and Contraindications

Serious Reactions: Rarely, fatalities have occurred due to severe reactions common to sulfonamides, including Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), fulminant hepatic necrosis, and severe blood dyscrasias (e.g., aplastic anemia, agranulocytosis). Hypersensitivity reactions require immediate discontinuation.

Contraindications: Use is restricted in patients with low serum sodium and/or potassium levels (hyponatremia/hypokalemia), marked kidney or liver disease (including cirrhosis due to the risk of hepatic encephalopathy), adrenal gland failure, and hyperchloremic acidosis. The concomitant use of high-dose aspirin is advised against due to reports of severe adverse effects, including coma and death.

Population/Safety Notes: Caution is advised in patients with pulmonary obstruction, emphysema, or diabetes mellitus, as the drug may aggravate or precipitate acidosis. Periodic monitoring of serum electrolytes and acid-base balance is recommended. Based on animal studies showing teratogenic effects (limb defects), use during pregnancy is advised only if the potential benefit outweighs the documented risks to the fetus. The drug may cause photosensitivity, requiring protective measures against sunlight.


Common Adverse Reactions

Adverse reactions that most often occur early in therapy include paresthesias (a tingling or “pins and needles” feeling in the extremities), a taste alteration (often a metallic or bitter taste), loss of appetite, and gastrointestinal disturbances (nausea, vomiting). Other common effects are increased urination (polyuria), drowsiness, and occasional instances of transient myopia (nearsightedness), which typically resolves upon cessation of the medication. The development of metabolic acidosis is a recognized consequence of the drug's mechanism of action.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information indicates that no cases of acute poisoning with Acetazolamide overdosage in humans have been formally reported. However, based on its function as a Carbonic Anhydrase Inhibitor, an overdose is expected to cause severe extensions of the drug's known effects. These anticipated manifestations involve critical disruptions to body chemistry:

  • Electrolyte Imbalance: A severe drop in essential blood electrolyte levels, particularly potassium.
  • Metabolic Acidosis: The development of a significant acidotic state (low blood pH levels).
  • Central Nervous System (CNS) effects.

Required Emergency Actions

No specific antidote is known for Acetazolamide overdosage. Therefore, treatment is mandated to be symptomatic and supportive, with the primary goal of restoring electrolyte and pH balance. If an overdose is suspected, you must contact a poison control center or emergency room at once.

Action Requirement
Monitoring Serum electrolyte levels and blood pH levels must be monitored.
Supportive Measure Hemodialysis may be beneficial in managing overdose, particularly if complicated by renal failure.

High-Risk Co-Ingestion

The most severe warning relates to co-administration: severe, potentially fatal toxicity, including coma and death, is specifically associated with the concomitant use of Acetazolamide and high-dose aspirin (acetylsalicylic acid).

Therapeutic Uses of Acetazolamida

Acetazolamide is applied across therapeutic domains that involve specific conditions and symptoms related to pressure and fluid imbalances, which may be part of symptomatic management. The medication may be part of symptomatic management across several domains, including conditions involving certain distressing symptoms such as those related to glaucoma, select epileptic seizure patterns, fluid retention (edema), and Acute Mountain Sickness (AMS).

“The goal of management is often to offer symptomatic relief that helps patients cope more steadily with difficult episodes and assists with maintaining functional stability.”


Therapeutic Focus and Symptom Relief

Managing High Eye Pressure

Acetazolamide is applied across therapeutic domains for addressing conditions like glaucoma that involve abnormally high fluid pressure (IOP) within the eye. Its primary benefit is providing support that may assist with managing pressure levels, which is important for supporting visual function and contributes to easing the overall symptom load related to potential functional decline in both recurrent symptomatic manifestations and acute episodes.

Quick Fact: Relief for Pressure Symptoms

The medication is relevant when symptoms are driven by internal fluid dynamics and pressure imbalances, providing supportive relief that is relevant for both recurrent symptomatic manifestations and acute episodes.


Easing Altitude Distress

The medication is generally considered relevant for addressing or reducing the distressing symptoms of AMS. It helps to moderate pronounced manifestations such as headache, dizziness, nausea, and fatigue, offering symptomatic relief that helps patients cope more steadily and supports a more manageable experience during rapid ascent to high altitudes. Acetazolamide may also be part of symptomatic management for select seizure types and certain cases of fluid accumulation.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Acetazolamida?

Eligibility for Acetazolamida is strictly determined by official regulatory documents, primarily based on the absence of specific pre-existing conditions and known hypersensitivity. The medicine is primarily approved for use in adults who do not have any contraindications.


Populations Strictly Prohibited (Contraindicated)

Acetazolamida must not be used in patients presenting with:

  • Marked Hepatic Impairment: Including cirrhosis, due to the risk of hepatic encephalopathy.
  • Marked Kidney Disease: As the drug's effectiveness is reduced and it may cause severe metabolic acidosis.
  • Electrolyte Imbalances: Specifically, depressed serum sodium (hyponatremia) or potassium (hypokalemia).
  • Hypersensitivity: Known allergy to acetazolamide or any sulfonamide (sulfa) derivatives.
  • Other Conditions: Adrenocortical insufficiency and pre-existing hyperchloremic acidosis.

Populations Requiring Restricted Use

Age Group / Condition Official Regulatory Status
Pediatric Use (Children) Safety and effectiveness are generally not established for immediate-release forms.
Older Adults (Geriatric) Use requires caution due to a greater likelihood of reduced organ (renal/hepatic) function.
Pregnancy / Lactation Use is restricted; permissible only if the potential benefit outweighs the potential risk to the fetus or child.

What should I know about interactions with other medicines?

Acetazolamide Interactions with Other Medicines and Products

Acetazolamide, a carbonic anhydrase inhibitor, can interact significantly with several other medications, potentially altering their effects or increasing the risk of adverse reactions. It is crucial to inform your healthcare provider about all prescription, over-the-counter, and herbal products you are currently taking.


Major Interactions

Drug Class or Specific Medicine Potential Interaction
High-Dose Aspirin (Salicylates) Increased risk of salicylate toxicity and metabolic acidosis. Concurrent use is generally not recommended.
Other Carbonic Anhydrase Inhibitors Increased risk of severe adverse effects and toxicity. Avoid concurrent use with drugs like dorzolamide or brinzolamide.
Lithium Acetazolamide may increase the excretion of lithium, potentially lowering its therapeutic effect. Monitoring of lithium levels is required.
Ciclosporin (Cyclosporine) Acetazolamide may increase ciclosporin plasma levels, leading to an elevated risk of nephrotoxicity and neurotoxicity.
Primidone, Phenytoin, Carbamazepine Acetazolamide may alter the metabolism of these antiepileptic drugs, potentially affecting seizure control.

Other Important Considerations

Concurrent use with diuretics (especially loop or thiazide) may increase the risk of hypokalemia (low potassium levels). The drug may also affect the plasma concentration of quinidine, necessitating close monitoring. Acetazolamide can interfere with some laboratory tests, leading to false results for certain electrolyte or glucose measurements.

Mechanism of Action

How Acetazolamide Works

Acetazolamide's action is fundamentally driven by the reversible inhibition of the Carbonic Anhydrase (CA) enzyme. This single molecular interaction modulates key physiological pathways across multiple organ systems, leading to predictable systemic effects.


Enzyme Inhibition and Molecular Target

Acetazolamide directly targets and inhibits the Carbonic Anhydrase enzyme, particularly isoforms found in the kidney, eye, and central nervous system. The drug's sulfonamide structure binds to the zinc ion in the enzyme's active site, blocking the conversion of CO2 and water into bicarbonate ( HCO3^-) and a proton ( H^+). This molecular blockade initiates the subsequent systemic and local physiological changes.


Modulation of Renal Fluid and Acid-Base Balance

In the renal proximal tubules, the drug's inhibition of CA prevents the necessary generation of H^+, which is required to drive the reabsorption of HCO3^- and Na^+. This failure of ion recovery leads to the increased urinary excretion of bicarbonate, sodium, and water, resulting in a systemic shift toward metabolic acidosis and increased urine volume.


Regulation of Specialized Fluid Secretion

Acetazolamide also inhibits CA in non-renal tissues, such as the ciliary body epithelium of the eye and the choroid plexus of the brain. By impairing the HCO3^--dependent active transport of fluid, the drug reduces the formation rate of aqueous humor and cerebrospinal fluid (CSF), which constitutes a reduction in fluid volume and pressure within these specialized compartments.

Dosage and Administration Information

Acetazolamide is administered systemically via either the oral route (using tablets or extended-release capsules) or the intravenous route (using a sterile powder). The medicine is available in strengths of 125 mg and 250 mg for immediate-release tablets, 500 mg for extended-release capsules, and 500 mg per vial for injection.

Usage is governed by specific dosing ranges and frequencies. For chronic simple glaucoma, the typical adult dose ranges from 250 mg to 1000 mg daily, often taken in divided doses, or 500 mg in the extended-release form once or twice per day. For diuresis associated with edema, a common regimen involves 250 mg to 375 mg administered once daily, often following a cyclic pattern of use, such as alternating days or two consecutive days of use followed by a rest day.

Specific procedural requirements must be followed for administration. The extended-release capsules must be swallowed whole and should not be crushed or chewed. When preparing the intravenous form, the sterile powder requires reconstitution with a minimum of 5 mL of Sterile Water for Injection prior to use. For older adults, the official guidance often advises using the lowest effective dose. Similarly, dose adjustments or extended dosing intervals are required for patients with documented renal impairment, which may involve limiting the dose or extending the interval to every 12 hours.

Recent Clinical Evidence

Acetazolamida: Research Evidence Overview

This section outlines the types of research that have been conducted on Acetazolamide. Studies help show what has been observed so far, but research does not determine whether an individual will respond similarly.


Research in Glaucoma

Research examined Acetazolamide in studies focused on intraocular pressure (IOP) changes. Trials often involved adult populations and monitored outcomes related to systemic or functional imbalance. Studies reported data show patterns related to changes in measured IOP. However, long-term effects are not fully established, and comparative evidence is lacking against other available treatments.


Research in High Altitude Sickness

Acetazolamide was evaluated in research exploring high altitude sickness. Research examined patterns related to symptom development and outcomes related to physical discomfort in ascending individuals. Findings indicate that studies reported patterns related to less frequent reported symptom incidence in observed groups during the short-term exposure period. Evidence remains limited regarding long-term physiological changes.


Research in Edema and Seizure Activity

Research monitored short-term patterns of fluid retention in conditions presenting with cycles of stability and flare-ups. Studies explored changes in measures of swelling and fluid output, often in a context where the treatment was studied as an adjunctive therapy alongside other medications. In research exploring certain seizure types, studies reported observed patterns related to symptom evolution when the drug was added to an existing regimen.


Uncertainty and Study Limitations

Across all indications, follow-up durations were limited in many key trials. Data for specific groups, such as pregnant populations, remain insufficient. Research describes that the evidence quality varies across studies, meaning further research is ongoing to fully characterize long-term effects.

Frequently Asked Questions (FAQ)

Common questions about Acetazolamida (FAQ)

Q: What are the main medical conditions Acetazolamida is officially prescribed to manage?

Official regulatory documents state that Acetazolamida is used for the adjunctive treatment of glaucoma and certain types of epilepsy. It is also prescribed to help manage fluid retention (edema) and for the prevention or relief of symptoms associated with acute mountain sickness (altitude sickness).

Q: Why is Acetazolamida used to treat conditions as different as glaucoma and altitude sickness?

The medicine works as a carbonic anhydrase inhibitor, an action that affects several different body systems. This mechanism reduces the secretion of aqueous humor in the eye for glaucoma, and separately, it helps acidify the blood to stimulate breathing, which aids in acclimatization to high altitude.

Q: Is Acetazolamida classified as a diuretic, a carbonic anhydrase inhibitor, or both?

According to the official product information, Acetazolamida is classified as both a diuretic (a water pill) and a carbonic anhydrase inhibitor.

Q: How does Acetazolamida work to help the body acclimatize to high altitude?

It works by affecting the enzyme carbonic anhydrase, which causes the kidneys to excrete bicarbonate. This action helps to subtly acidify the blood, which in turn helps to stimulate breathing to compensate for the lower oxygen levels at high altitudes.

Q: Does the mechanism of Acetazolamida involve reducing fluid production in the eyes or brain?

Yes, the medicine's mechanism of action involves reducing the secretion of aqueous humor in the eye. It can also affect the production of cerebrospinal fluid, which is relevant to some of its uses.

Q: Is the tingling or numbness (paresthesia) in the hands and feet a common side effect?

Official adverse reaction reports indicate that paresthesia, which feels like tingling or numbness, especially in the hands and feet, is a commonly reported side effect.

Q: Why do carbonated drinks taste metallic or strange when taking Acetazolamida?

Taste alteration (known as dysgeusia), which can include a bitter or metallic taste, is a reported adverse effect. This change in taste is commonly noticed by users when drinking carbonated beverages.

Q: How long after starting the medicine can I expect the tingling side effect to last?

The tingling sensation is often described as temporary and can be related to the dosage being used. Regulatory patient guidance indicates that the reaction may subside if the dosage is reduced or if the medication is stopped.

Q: Is it necessary to increase fluid intake because Acetazolamida can cause increased urination?

As a diuretic, the drug causes increased excretion of water, which results in increased urination (polyuria). The prescribing information notes the importance of monitoring for potential electrolyte imbalances and the risk of developing kidney stones.

Q: What are the official warnings regarding the use of Acetazolamida in people with a sulfa allergy?

Acetazolamida is chemically related to sulfonamide derivatives, and regulatory documents state that it is contraindicated for people with a known history of hypersensitivity to Acetazolamida or other sulfonamide drugs.

Q: Does Acetazolamida use increase the risk of developing kidney stones?

Yes, renal calculus (kidney stones) is a known adverse reaction reported in association with the use of Acetazolamida, particularly during long-term treatment.

Q: What are the known severe or less common side effects that require immediate medical attention?

Regulatory warnings highlight the potential for severe adverse effects, including serious skin reactions like Stevens-Johnson syndrome, certain blood disorders (e.g., aplastic anemia), liver injury, and severe electrolyte imbalance or metabolic acidosis.

Q: Are headaches a commonly reported side effect when starting Acetazolamida?

Yes, headache is listed in the official adverse reactions section as one of the commonly reported side effects of the medication.

Q: Is Acetazolamida generally intended for short-term use, or is it approved for long-term treatment?

The approved use of this medicine varies by condition; for example, it is used for chronic simple glaucoma. However, long-term administration is specifically contraindicated in other types of glaucoma, indicating usage patterns vary based on specific medical need.

Q: How quickly does the effect of Acetazolamida start when used for altitude sickness prevention?

Regulatory documents indicate that for the prevention of acute mountain sickness, the treatment is often started 24 to 48 hours prior to ascent. It is then continued while a person remains at high altitude or until symptoms resolve.

Q: Is it possible to reduce stomach upset by taking Acetazolamida with food?

To help address common gastrointestinal side effects such as nausea or vomiting, official patient guidance indicates that taking the medicine with food is an option.

Q: What are the general guidelines for using Acetazolamida with alcohol?

According to regulatory warnings, consuming alcohol can increase the risk or severity of central nervous system side effects. These can include feelings of drowsiness or reduced alertness.

Q: Are there any major over-the-counter pain relievers that interact with Acetazolamida?

Official documents specifically advise caution regarding the use of concomitant high-dose aspirin. This combination has been associated with severe toxicity, including metabolic acidosis.

Q: How does Acetazolamida interact with high-dose aspirin, according to official information?

The label advises caution when the medicine is used with concomitant high-dose aspirin. This combination has been linked to severe toxicity, including metabolic acidosis, lethargy, and coma.

Q: Is there a known interaction between Acetazolamida and blood pressure medications?

As a diuretic, the medicine can cause electrolyte imbalances such as low potassium, which can be affected by other blood pressure medicines. The prescribing information notes the importance of monitoring for these potential interactions.

Q: What does official guidance say about using Acetazolamida during pregnancy?

The medicine is considered teratogenic in animals (causing developmental toxicity). Regulatory guidance advises that its use during pregnancy involves careful consideration of the potential risks and benefits, with some sources recommending avoidance in the first trimester.

Q: Is Acetazolamida use permitted while breastfeeding?

The official product label notes that the medication's use during breastfeeding requires careful consideration, as Acetazolamida is known to be excreted in breast milk.

Q: What pre-existing health conditions, like kidney or liver problems, may affect eligibility to use Acetazolamida?

The medication is contraindicated (should not be used) in people with marked kidney or liver disease. It is also contraindicated in those with adrenal gland failure and certain forms of acidosis.

Q: Is Acetazolamida use contraindicated for people with certain electrolyte imbalances (e.g., low potassium)?

Yes, official product information states that the medicine is contraindicated for use when serum levels of sodium or potassium are depressed (meaning they are too low).

Q: What is the current research status on the effectiveness of Acetazolamida for Idiopathic Intracranial Hypertension (IIH)?

Idiopathic Intracranial Hypertension (IIH), a condition involving pressure around the brain, is listed as an FDA-approved indication for Acetazolamida.

Q: How is Acetazolamida related to other carbonic anhydrase inhibitors like Methazolamide?

Acetazolamida is classified as a carbonic anhydrase inhibitor. The official prescribing information generally notes that its concomitant use with other carbonic anhydrase inhibitors is typically avoided due to the potential for increased effects and toxicity.

Q: Does Acetazolamida cause a change in blood sugar levels that might affect people with diabetes?

Regulatory documents report that both increases and decreases in blood glucose levels have been associated with its use. The product information recommends caution for patients with impaired glucose tolerance or diabetes mellitus.

Q: Is it normal to feel unusually fatigued or tired during the first few weeks of taking Acetazolamida?

Yes, feelings of fatigue and drowsiness are listed as commonly reported adverse effects. These effects may impact alertness and ability to perform tasks like driving or operating machinery.

Q: Can Acetazolamida be stopped suddenly, especially for conditions like epilepsy, without specific instructions?

In general, regulatory patient information notes that the dosage is typically recommended to be gradually reduced before the medication is completely stopped. This approach is often taken when treating conditions like epilepsy.

Q: Why is there a recommendation to protect skin from the sun while using Acetazolamida?

The medicine has been associated with photosensitivity (increased sensitivity to sunlight), which is listed as a potential allergic skin reaction. Measures to protect the skin from sun exposure are commonly recommended during its use.

Q: Does Acetazolamida affect the way the body processes other medications by the liver or kidneys?

Acetazolamida can alter the body's processing of other medications by affecting their urinary excretion. This may result in either increased or decreased levels of the co-administered drug in the body.

Q: What information is available about Acetazolamida's effect on heart rate?

Low potassium levels (hypokalemia) are a potential adverse effect listed in official documents. Symptoms of low potassium can include a fast or irregular heartbeat.

Q: Can Acetazolamida cause a temporary change in vision or short-sightedness?

The drug has been associated with transient myopia (a temporary change toward short-sightedness). This visual change typically resolves when the medication dosage is reduced or if the drug is stopped.

Q: How is the weight loss sometimes reported by users linked to the action of Acetazolamida?

Any weight changes may be linked to the drug's diuretic effect, which helps the body excrete excess water. It is also related to the reported side effect of loss of appetite.

Q: What are the general safety guidelines for using Acetazolamida in older adults?

The product label notes that the use of this medicine in older adults requires careful consideration. This is because elderly patients are more likely to have underlying health problems, and monitoring of renal function is noted as an important measure.

Q: How is Acetazolamida different from loop diuretics or thiazide diuretics?

Acetazolamida is classified as a carbonic anhydrase inhibitor, which means it works through a different mechanism than other classes of water pills. It is chemically and mechanically distinct from diuretic classes like loop or thiazide diuretics.

Q: Does the effectiveness of Acetazolamida decrease over time for certain conditions (tolerance)?

For certain conditions, particularly when treating epilepsy, the drug's effectiveness may be transient (short-lived). This is due to the potential development of tolerance over time.

Q: What are the signs of metabolic acidosis that can be associated with Acetazolamida use?

Signs of metabolic acidosis, a potential side effect, can include fast or irregular breathing or heartbeat, unusual weakness or fatigue, and confusion.

How should Acetazolamida be stored and disposed of?

Storage and Disposal Requirements for Acetazolamide

Acetazolamide tablets and the unreconstituted powder for injection must be stored at Controlled Room Temperature, specifically 20 C to 25 C (68 F to 77 F). The medicine must be kept in a closed container and protected from heat, light, and moisture. It is required to store this medicine out of the reach of children.


Stability and Handling

The reconstituted solution for injection has a limited stability and must be used within 12 hours of mixing. During this period, it may be stored refrigerated (2 C to 8 C) or at room temperature.

Disposal

Unused or expired product should be discarded according to official instructions, such as utilizing a drug take-back program. If a program is unavailable, follow the guidance for mixing the product with an undesirable substance before disposal in the household trash, in compliance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acetazolamida found in:

A-Z Index: